OptraSCAN® receives First U.S. Patent for whole slide storage, retrieval, transfer and scanning system
San Jose, CA, 23rd May 2019: OptraSCAN®, the leading end-to-end digital pathology solution provider today announced that the United States Patent and Trademark Office has granted it a first patent for whole slide handling, relating to digital pathology offerings.
OptraSCAN has patented an invention that describes a system for slide storage, retrieval, and transfer for microscopy slide scanning that is robust, automated, accurate, simple to use, low cost and picks up slides of various thicknesses, holds them securely during the scanning process and deposits them back into slide storage once the scanning is complete.
“It’s a wonderful feeling to get the patent that underscores uniqueness of our invention globally. OptraSCAN systems are world’s first affordable systems to transform age old microscopy devices into digital avatar. Our invention speaks about our design approaches that helped us achieve price disruption without compromising quality of images. With CE mark for IVD use, we are now ready to storm the market with a mission to replace microscope from every desk by OptraSCAN”, said Abhi Gholap, Founder & CEO, OptraSCAN. “Our recent multi-institutional study at Duke, Yale and USC has helped us validate our AI/ ML platform for automated biomarker quantification studies related to PD-L1 in non–small cell lung cancer,” he further added.
On this occasion, stellar advisory board of OptraSCAN consisting of 4 chairmen of Pathology at prestigious institutions viz. Stanford, Duke, Yale and UCSF congratulated team OptraSCAN.
An ISO 13485 certified company and CE marked whole slide scanners for IVD use, OptraSCAN® has developed world’s first ‘On-Demand Digital Pathology’ System; focused on delivering fully integrated, affordable systems & solutions. These serve as the perfect tool for transition from conventional microscopy to Digital Pathology for the effective acquisition of whole slide images, viewing, storing, real time sharing, and reporting via On-Demand or outright purchase model. Follow Us on LinkedIn and Twitter.
Media Inquiries Contact: